| Jun 24 |
Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion
|
| Jun 6 |
Spruce Biosciences Recognized as a Bay Area Best Place to Work
|
| Jun 4 |
Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
|
| Jun 4 |
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
|
| Jun 3 |
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
|
| May 23 |
Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
|
| May 22 |
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
|
